Biomarker gauges graft-versus-host disease risk for stem cell transplant patients Proactive Investors USA & Canada A newly identified biomarker can help spot stem cell transplant patients who are at high risk for graft-versus-host disease, and they can be screened through a blood test. The research team determined that patients with high levels of the ST2 protein ... |
